Abstract

Immunoglobulin (Ig) G4-related disease (IgG4-RD) is a novel clinical disease entity characterized by an elevated serum IgG4 concentration and tumefaction or tissue infiltration by IgG4-positive plasma cells. Pathological changes are most frequently seen in the pancreas, lacrimal glands, and salivary glands, but pathological changes in the lung also exist. Linker for activation of T cell (LAT)Y136F knock-in mice show Th2-dominant immunoreactions with elevated serum IgG1 levels, corresponding to human IgG4. We have reported that LATY136F knock-in mice display several characteristic features of IgG4-RD and concluded that they constitute an appropriate model of human IgG4-RD in salivary glands, pancreas, and kidney lesions. The aim of this study is to evaluate whether lung lesions in LATY136F knock-in mice can be a model of IgG4-related lung disease. Lung tissue samples from LATY136F knock-in mice (LAT) and wild-type mice (WT) were immunostained for IgG1 and obtained for pathological evaluation, and cell fractions and cytokine levels in broncho-alveolar lavage fluid (BALF) were analyzed. In the LAT group, IgG1-positive inflammatory cells increased starting at 4 weeks of age and peaked at 10 weeks of age. The total cell count and percentage of lymphocytes increased significantly in BALF in the LAT group compared to the WT group. In BALF, Th2-dominant cytokines and transforming growth factor-β were also increased. In the LAT group, marked inflammation around broncho-vascular bundles peaked at 10 weeks of age. After 10 weeks, fibrosis around broncho-vascular bundles and bronchiectasis were observed in LATY136F knock-in mice but not WT mice. LATY136F knock-in mice constitute an appropriate model of lung lesions in IgG4-RD.

Highlights

  • In recent years, immunoglobulin (Ig) G4-related disease (IgG4-RD) has been established as a new disease entity [1]

  • The aim of this study is to evaluate whether lung lesions in LATY136F knock-in mice can be a model of IgG4-related lung disease

  • LATY136F knock-in mice constitute an appropriate model of lung lesions in IgG4-RD

Read more

Summary

Introduction

Immunoglobulin (Ig) G4-related disease (IgG4-RD) has been established as a new disease entity [1]. IgG4 is a subclass of IgG without complement binding ability and is associated with a decrease in symptoms in the context of IgE-mediated allergy due to an allergen-blocking effect at the mast cell level and/or at the level of the antigen-presenting cell [5] This means that IgG4-RD has IgE-mediated type I allergy as a characteristic of the disease, and IgG4 as a blocking antibody may accumulate in each organ. Interleukins (IL) 4, 5, 10, and 13 and transforming growth factor β (TGF-β) are overexpressed through an immune reaction in which type 2 helper T cells (Th2) predominate, followed by activation of regulatory T cells [7] These cytokines contribute to eosinophilia, elevated serum IgG4 and IgE concentrations, and progression of fibrosis that are characteristic of IgG4-RD [8]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call